Medical Device Company ZetrOZ and Clinical Research

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Medical Device Company ZetrOZ and Clinical Research Partners Present Positive Results of NIH-Funded Clinical Studies at IEEE and World Physiotherapy Congress

TRUMBULL, CT--(Marketwired - May 4, 2015) - ZetrOZ announced positive results for the company's Phase I pilot study of its sam® device (Long Duration, Low Intensity Therapeutic Ultrasound Intervention for Osteoarthritis Pain Management) at The Institute of Electrical and Electronics Engineers, Inc. (IEEE) bioengineering conference. The results from the phase II randomized controlled trial were also competed successfully early this year and are being presented at The World Physiotherapy Congress in Singapore this week.

Results from the sam pilot studies show:

  • Significant decrease in pain, as measured by a visual analog scale for pain (phase l study).
  • Twenty percent increase in mobility in the treatment group, measured by a pedometer, and range of motion and strength both increased (phase I study).
  • Forty per cent decrease in pain in the phase II randomized controlled trial on 47 subjects completed in January 2015 confirmed these findings on patients with moderate to severe arthritis pain as compared to 17% in the placebo group, which is clinically and statistically significant.

According to George K. Lewis, Jr., PhD, ZetrOZ Chief Scientific and Technology Officer, and Principal Investigator for the study, this work demonstrates the role for long-duration, low-intensity therapeutic ultrasound in the treatment of musculoskeletal pain resulting from osteoarthritis, as well as its impact on mobility and joint stiffness. The U.S. Center for Disease Control and Prevention estimates that 50 million adults in the U.S. have some form of arthritis, and that approximately one in two people will develop symptomatic knee osteoarthritis in their lifetime. 

"Persistent pain whether from arthritis or other pain-producing conditions is the number-one reason that patients access the healthcare system, according to the National Institutes of Health," said Dr. Lewis. "Pain seriously affects a patient's quality of life. While medications are often the first-line treatment for pain, they're not without side effects such as nausea, stomach pain, diarrhea and drowsiness. The ZetrOZ device does not negatively affect patients in these ways."  

"I was impressed with the outcome of this phase II clinical trial," said Dr. Ralph Ortiz, DO, MPH. "The use of sam showed clinically significant pain reduction and increase in range of motion over placebo. Also impressive were the active patient's improvement in quality of life. Further studies may indicate a slowing of the disease progression using sam, as therapeutic ultrasound has already been shown to enhance collagen production."

A longitudinal study intended to broaden these positive results on osteoarthritis pain reduction and study the effect of the intervention to slow progression of the debilitating disease is anticipated.

Lieutenant Governor Nancy Wyman has been a strong supporter of the partnership between ZetrOZ and the NIH in an ongoing and successful effort to promote Connecticut's biotech industry. The National Institutes of Health SBIR program which provided the initial funding for the study is a peer-reviewed grant program that provides research support to small businesses to discover and develop innovative biomedical products for the treatment of serious unmet medical needs.

About Ultrasound Ultrasound has been used safely and effectively for years to provide pain relief and reduce joint contracture (stiffness). Additionally, the mechanical and thermal mechanisms triggered by ultrasound have been shown to facilitate wound and bone fracture healing, promote the penetration of topical ointments into the skin, and increase local circulation with a cascade of therapeutic biological benefit. Despite the potential of ultrasound therapy for treatment of pain and for healing, the therapy's mode of delivery, ease of safe and effective use, size of device, and price have traditionally prohibited its broad translation to the public. ZetrOZ ultrasound technology relies on aggressive miniaturization and integration of the ultrasound transducer, electronics, and power supply to produce a smaller, controlled release ultrasound system that can deliver portable, convenient, and effective therapy for long durations. 

About ZetrOZ, Inc. ZetrOZ is a medical device manufacturer that is revolutionizing the medical therapeutic industry by introducing proprietary technology that is more efficient, more portable, and more economically viable than any ultrasound systems presently available. ZetrOZ's first product is the world's smallest and strongest ultrasound pain therapy device. The device was released in 2014, and is intended to addresses the demand for non-pharmaceutical alternatives to current pain treatments in the approximately $100 billion U.S. musculoskeletal pain management market. ZetrOZ is also known for developing the smallest ultrasound systems in the world, including the first swallowable ultrasound pill, and is the winner of numerous awards, including the 2014 Connecticut Technology Summit's Most Promising New Technology Product Company of the Year, the 2014 Beacon Medical Technology Award and 2013 Medical Device Excellence Award. For more information, visit www.zetroz.com .

Media Contacts: Eri Mizobe Crenshaw Communications for ZetrOZ Inc. (212) 367-9700 eri@crenshawcomm.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

GALC Launches Tender Offer on 2027 Notes Amid Debt Play

Updated Category News Views 70

Aviation Leasing Giant's Strategic Financial Move Well folks, we're staring down the barrel of a financial maneuver by Global Aircraft Leasing Co., Ltd. (GALC) that’s not just another day at the office. They've kicked off a cash tender offer for their 8.750% Senior Secured Notes due 2027, aiming to sweep up any and all outstanding ones. That's $932 million in principle...

Continue Reading
Cracking Life Insurance Needs: John Dorsa's Insights

Updated Category News Views 119

Life Insurance: A Necessary Puzzle Life’s uncertainties have a way of putting a wrench in our plans, and nothing screams uncertainty like figuring out life insurance. But fret not! HelloNation’s got insights on this financial maze, and they’ve roped in insurance pro John Dorsa from Ridgeland to help out. Calculating Coverage Needs Forget the one-size-fits-all...

Continue Reading
Choate's Expands to New Mid-South Markets

Updated Category News Views 155

Family Traditions Drive Choate's Growth Back in the day, you might've thought the family-run businesses were a dying breed, right? Not in the case of Choate's Air Conditioning, Heating, Plumbing & Electrical. These folks aren't just holding the fort; they're storming new territories across the Mid-South like they've got something to prove—or maybe just something to...

Continue Reading
Zettia R. Barnes: Charting a Path in Home Healthcare

Updated Category News Views 146

The Lifeline of Home Healthcare in DeSoto You know, it ain't every day that someone like Zettia R. Barnes steps up in the realm of home healthcare and makes a mark that genuinely sticks. From rubbing shoulders with patients to steering a whole dang organization like Angels of Hands Home Health Agency Corp., she's got her hands full—and frankly, it’s folks like her who...

Continue Reading
Texxon Faces Revenue Slide Amid Strategic Shifts

Updated Category News Views 108

Texxon's Strategic Transitions and Financial Headaches Texxon Holding Limited (NASDAQ:NPT) just laid their cards on the table, unveiling a mixed bag in their fiscal year 2026 results. As the world's chemical and plastics scene faces winds of change, Texxon buckled down and tried to steer the ship clear from the rocks. It's a balancing act juggling market headwinds, a new...

Continue Reading
Québecor Makes Its Move: Eye on TELUS Amid Telecom Shakeup

Updated Category News Views 142

The Offer That Shocked the Telecom Markets Just when you think you’ve figured out the lay of the land, someone throws a curveball. Québecor’s decision to take a run at TELUS is shaking up Canada’s telecom scene big time. This isn’t just another M&A whisper; it’s a roaring freight train of a proposal valued at a whopping $31 billion. And TELUS, not just sitting...

Continue Reading
Paris Baguette Expands U.S. Presence with New Georgia Café

Updated Category News Views 163

Café Culture Meets Expansion Chase You ever sip a cup of coffee and hear the rustle of opportunity in the steam? That's what's brewing at Paris Baguette with their new opening in Peachtree Corners, Georgia. This isn't just another café setting up shop; it's part of a larger scheme—expanding their sweet slice of the global market pie. Paris Baguette's Georgia Gamble...

Continue Reading
Ranger and Smith Unveil Tea-Infused Chocolate Bar

Updated Category News Views 88

Fresh Collaborations in Portland's Culinary Scene Ah, the sweet crossover in Portland's food scene is once again in the spotlight with a new entry that's sure to titillate taste buds. Ranger Chocolate Co. and Steven Smith Teamaker are at it again, rolling out a delectable creation that merges the poetic elegance of tea with the indulgent richness of chocolate. Welcome,...

Continue Reading
Intel Hit by Securities Law Suit Amid PC Market Struggles

Updated Category News Views 100

Intel Faces the Music: Legal Battles Unfold So it seems Intel's got itself in a kettle of fish. The tech giant is being dragged into a courtroom dance, courtesy of a class action lawsuit led by DJS Law Group. Shareholders who snapped up Intel shares between July 23 and October 29, 2026, might be scratching their heads, wondering if they bought into a bit of a mirage. A...

Continue Reading
NVCA Refreshes Key Venture Legal Documents for 2026

Updated Category News Views 115

Keeping Pace with Evolving Venture Norms Change never lets up in the fast-paced world of venture capital, does it? Just when you think you've got the rules figured out, the game shifts. This time, it's the National Venture Capital Association (NVCA) shaking things up. They've given a facelift to seven of their model legal documents, a move that reshapes the legal...

Continue Reading

Top 5 Most Recently Viewed Articles

Lake Chelan Health Partners with Medline for Improved Care

Updated Category News Views 364

Lake Chelan Health's Collaboration with Medline In an exciting development, Lake Chelan Health, a critical access hospital located in Washington, has entered into a strategic Prime Vendor agreement with Medline, one of the leading suppliers of medical-surgical products. This partnership is set to elevate their supply chain resilience and enhance the availability of...

Continue Reading
Investors of Dow Inc. Urged to Join Class Action Lawsuit

Updated Category News Views 232

Invitation for Dow Inc. Investors Are you an investor in Dow Inc. (DOW)? If you have faced significant losses during a certain period, there is an opportunity for you to become involved in a class action lawsuit. This is especially important for those who acquired Dow securities from January 30, 2025 to July 23, 2025. Individuals who believe they are eligible are...

Continue Reading
Strategic Growth at Future Technologies with New Chairperson

Updated Category News Views 197

Future Technologies Ventures Welcomes New Leadership In a strategic move to enhance its operations, Future Technologies Venture, LLC recently appointed Mary Peterson as Chairperson of its Advisory Board. This significant addition comes after a recapitalization with Battle Investment Group, marking an exciting chapter for the company. Mary Peterson's Role in Future...

Continue Reading
Cineverse Brings Halloween Thrills with 31-Day SCREAMBOX Event

Updated Category News Views 180

Cineverse's 31 Days of Halloween Celebration Cineverse is gearing up for an exciting Halloween season with their unique event, 31 Days of Halloween, hosted on their SCREAMBOX streaming service. This initiative aims to deliver chilling thrills and engaging experiences tailored for horror enthusiasts around the globe. Featured Film Premiere: Bloodsuckers and the Grimoire...

Continue Reading
ParkerVision Prevails Against Qualcomm in U.S. Federal Court

Updated Category News Views 77

ParkerVision Achieves a Legal Milestone Against Qualcomm The legal battle between ParkerVision and Qualcomm has taken a notable turn, with ParkerVision recently securing a significant victory. The U.S. Court of Appeals for the Federal Circuit has delivered a favorable opinion, marking an important moment for ParkerVision as it strives to safeguard its intellectual...

Continue Reading